Shenzhen Rivaroxaban Co.,Ltd
Home
About us
Products
Rivaroxaban
Pharmaceutical Intermediates
Tegprazan
VeMurafenib
Anti-diabetic
Antiviral Drug
Antidepressants
Anti-cancer Drugs
High Polymer Materials
Complementary Medicines
Cardiovascular Medications
News
Blog
Contact us
Language
English
Français
Deutsch
Español
Italiano
Português
日本語
한국어
Русский
Home
>
News
LATEST NEWS
Leading By Example
Beyfortus Provides RSV Protection for Kids
U.S. FDA Approves Merck’s ERVEBO® (Ebola Zaire Vaccine, Live) for Use in Children 12 Months of Age and Older
New molecules fight viruses by popping their 'bubbles'
Efficacy of three antimicrobial mouthwashes in reducing SARS
Jul 19, 2023
Leading By Example
read more +
Jul 17, 2023
Beyfortus Provides RSV Protection for Kids
read more +
Jul 15, 2023
U.S. FDA Approves Merck’s ERVEBO® (Ebola Zaire Vaccine, Live) for Use in Children 12 Months of Age and Older
read more +
Jul 13, 2023
New molecules fight viruses by popping their 'bubbles'
read more +
Jul 11, 2023
Efficacy of three antimicrobial mouthwashes in reducing SARS
read more +
Jul 09, 2023
Gilead Showcases Latest HIV Pipeline Progress and the Impact of Global Collaboration on Health Equity Efforts at IAS 2023
read more +
Jul 07, 2023
Extended Antidepressant Therapy Curbs Relapses in Bipolar Disorder
read more +
Jul 05, 2023
Wellbutrin vs. Lexapro: Which Is Right For You?
read more +
Jul 03, 2023
Risks Outweigh Benefits for Antidepressants in Elderly, Study Concludes
read more +
Jul 01, 2023
Sage hopes for a blockbuster in antidepressant now before FDA
read more +
Jun 29, 2023
Antidepressants Diminish Psilocybin Psychedelic Effects
read more +
Jun 27, 2023
'The Onion' Explains the Surprising Reason Behind Antidepressants' Effectiveness
read more +
first
1
2
3
4
5
last